newsfilter
← Latest News
FDA Approved Drugs·

Approval of Inpefa, Nda #216203 (Labeling)

Approval Date: 08/06/2026; Drug Name: Inpefa, Nda #216203; Active Ingredients: SOTAGLIFLOZIN; Company: Lexicon Pharms Inc; Submission Status: Approval; Submission Classification: Labeling; Application Number: 216203

Company
LEXICON PHARMS INC
Keywords
LEXICON PHARMS INC